healthcare
March 25, 2023
Health meet focuses on impact of infectious diseases on people
Qatar’s healthcare partners recently hosted the first Qatar Infectious Disease Conference at the Itqan Clinical Simulation and Innovation Centre......
Continue Reading >
March 24, 2023
QLM recognises long serving employees
QLM Life & Medical Insurance Company Q.P.S.C recently honoured its employees with long-service awards for completing service milestones of 5,......
Continue Reading >
March 16, 2023
University of Nebraska Medical Center and ANANDA Scientific announce First Patient Enrolled in FDA-approved clinical trial for Post-Traumatic Stress Disorder (PTSD)
The University of Nebraska Medical Center (UNMC) and ANANDA Scientific Inc. today announced that the first patient has been enrolled in an FDA-approved......
Continue Reading >
March 16, 2023
Innovation in Resistance Management: VECTRONTM T500, a New Vector Control Product, is Prequalified by the World Health Organization (WHO)
VECTRONTM T500 is a new IRS product containing TENEBENALTM, the world’s first meta-diamide active ingredient (IRAC Group 30) developed by Mitsui......
Continue Reading >
March 13, 2023
Region’s first Global Robotic MedTech Forum to reveal latest advancements in robotic surgery
The US Society of Robotic Surgery and Crescent Healthcare (a Division of the Crescent Group of Companies) host the first Global Robotic MedTech Forum......
Continue Reading >
March 7, 2023
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients
Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British Journal of Neurosurgery in which Dr. Ankita Dey......
Continue Reading >
March 1, 2023
Aamal Company inks MoU with Egyptian Ministry of Health and Population
Doha: Aamal Company Q.P.S.C. (Aamal), one of the region’s leading diversified companies, announced the signing of a memorandum of understanding......
Continue Reading >
February 23, 2023
Hikma delivers a resilient underlying performance in 2022
Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its preliminary audited......
Continue Reading >
February 23, 2023
Ferrer Acquires Worldwide Rights to ASN90, an O-GlcNAcase Inhibitor From Asceneuron, Exclusively to Treat Progressive Supranuclear Palsy (PSP)
Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron announce the signing of a licensing agreement in......
Continue Reading >
February 23, 2023
LevitasBio Launches LeviSelect Suite of Cell Depletion & Enrichment Kits
LevitasBio, Inc. (www.levitasbio.com), a premier end-to-end sample processing and cellular analysis provider to the life sciences market, unveils......
Continue Reading >